Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR T-Cell Therapy Agents Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 CD19-targeted
1.2.3 BCMA-targeted
1.3 Market by Application
1.3.1 Global CAR T-Cell Therapy Agents Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Lymphoma
1.3.3 Multiple Myeloma
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CAR T-Cell Therapy Agents Market Perspective (2018-2029)
2.2 Global CAR T-Cell Therapy Agents Growth Trends by Region
2.2.1 CAR T-Cell Therapy Agents Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 CAR T-Cell Therapy Agents Historic Market Size by Region (2018-2024)
2.2.3 CAR T-Cell Therapy Agents Forecasted Market Size by Region (2024-2029)
2.3 CAR T-Cell Therapy Agents Market Dynamics
2.3.1 CAR T-Cell Therapy Agents Industry Trends
2.3.2 CAR T-Cell Therapy Agents Market Drivers
2.3.3 CAR T-Cell Therapy Agents Market Challenges
2.3.4 CAR T-Cell Therapy Agents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue CAR T-Cell Therapy Agents by Players
3.1.1 Global CAR T-Cell Therapy Agents Revenue by Players (2018-2024)
3.1.2 Global CAR T-Cell Therapy Agents Revenue Market Share by Players (2018-2024)
3.2 Global CAR T-Cell Therapy Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of CAR T-Cell Therapy Agents, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global CAR T-Cell Therapy Agents Market Concentration Ratio
3.4.1 Global CAR T-Cell Therapy Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR T-Cell Therapy Agents Revenue in 2022
3.5 Global Key Players of CAR T-Cell Therapy Agents Head office and Area Served
3.6 Global Key Players of CAR T-Cell Therapy Agents, Product and Application
3.7 Global Key Players of CAR T-Cell Therapy Agents, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR T-Cell Therapy Agents Breakdown Data by Type
4.1 Global CAR T-Cell Therapy Agents Historic Market Size by Type (2018-2024)
4.2 Global CAR T-Cell Therapy Agents Forecasted Market Size by Type (2024-2029)
5 CAR T-Cell Therapy Agents Breakdown Data by Application
5.1 Global CAR T-Cell Therapy Agents Historic Market Size by Application (2018-2024)
5.2 Global CAR T-Cell Therapy Agents Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America CAR T-Cell Therapy Agents Market Size (2018-2029)
6.2 North America CAR T-Cell Therapy Agents Market Size by Type
6.2.1 North America CAR T-Cell Therapy Agents Market Size by Type (2018-2024)
6.2.2 North America CAR T-Cell Therapy Agents Market Size by Type (2024-2029)
6.2.3 North America CAR T-Cell Therapy Agents Market Share by Type (2018-2029)
6.3 North America CAR T-Cell Therapy Agents Market Size by Application
6.3.1 North America CAR T-Cell Therapy Agents Market Size by Application (2018-2024)
6.3.2 North America CAR T-Cell Therapy Agents Market Size by Application (2024-2029)
6.3.3 North America CAR T-Cell Therapy Agents Market Share by Application (2018-2029)
6.4 North America CAR T-Cell Therapy Agents Market Size by Country
6.4.1 North America CAR T-Cell Therapy Agents Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America CAR T-Cell Therapy Agents Market Size by Country (2018-2024)
6.4.3 North America CAR T-Cell Therapy Agents Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe CAR T-Cell Therapy Agents Market Size (2018-2029)
7.2 Europe CAR T-Cell Therapy Agents Market Size by Type
7.2.1 Europe CAR T-Cell Therapy Agents Market Size by Type (2018-2024)
7.2.2 Europe CAR T-Cell Therapy Agents Market Size by Type (2024-2029)
7.2.3 Europe CAR T-Cell Therapy Agents Market Share by Type (2018-2029)
7.3 Europe CAR T-Cell Therapy Agents Market Size by Application
7.3.1 Europe CAR T-Cell Therapy Agents Market Size by Application (2018-2024)
7.3.2 Europe CAR T-Cell Therapy Agents Market Size by Application (2024-2029)
7.3.3 Europe CAR T-Cell Therapy Agents Market Share by Application (2018-2029)
7.4 Europe CAR T-Cell Therapy Agents Market Size by Country
7.4.1 Europe CAR T-Cell Therapy Agents Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe CAR T-Cell Therapy Agents Market Size by Country (2018-2024)
7.4.3 Europe CAR T-Cell Therapy Agents Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China CAR T-Cell Therapy Agents Market Size (2018-2029)
8.2 China CAR T-Cell Therapy Agents Market Size by Type
8.2.1 China CAR T-Cell Therapy Agents Market Size by Type (2018-2024)
8.2.2 China CAR T-Cell Therapy Agents Market Size by Type (2024-2029)
8.2.3 China CAR T-Cell Therapy Agents Market Share by Type (2018-2029)
8.3 China CAR T-Cell Therapy Agents Market Size by Application
8.3.1 China CAR T-Cell Therapy Agents Market Size by Application (2018-2024)
8.3.2 China CAR T-Cell Therapy Agents Market Size by Application (2024-2029)
8.3.3 China CAR T-Cell Therapy Agents Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia CAR T-Cell Therapy Agents Market Size (2018-2029)
9.2 Asia CAR T-Cell Therapy Agents Market Size by Type
9.2.1 Asia CAR T-Cell Therapy Agents Market Size by Type (2018-2024)
9.2.2 Asia CAR T-Cell Therapy Agents Market Size by Type (2024-2029)
9.2.3 Asia CAR T-Cell Therapy Agents Market Share by Type (2018-2029)
9.3 Asia CAR T-Cell Therapy Agents Market Size by Application
9.3.1 Asia CAR T-Cell Therapy Agents Market Size by Application (2018-2024)
9.3.2 Asia CAR T-Cell Therapy Agents Market Size by Application (2024-2029)
9.3.3 Asia CAR T-Cell Therapy Agents Market Share by Application (2018-2029)
9.4 Asia CAR T-Cell Therapy Agents Market Size by Region
9.4.1 Asia CAR T-Cell Therapy Agents Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia CAR T-Cell Therapy Agents Market Size by Region (2018-2024)
9.4.3 Asia CAR T-Cell Therapy Agents Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Market Size by Type
10.2.1 Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Market Size by Application
10.3.1 Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Market Size by Country
10.4.1 Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis CAR T-Cell Therapy Agents Introduction
11.1.4 Novartis Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.1.5 Novartis Recent Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences CAR T-Cell Therapy Agents Introduction
11.2.4 Gilead Sciences Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.2.5 Gilead Sciences Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Agents Introduction
11.3.4 Bristol-Myers Squibb Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 J & J
11.4.1 J & J Company Details
11.4.2 J & J Business Overview
11.4.3 J & J CAR T-Cell Therapy Agents Introduction
11.4.4 J & J Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.4.5 J & J Recent Developments
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Details
11.5.2 JW Therapeutics Business Overview
11.5.3 JW Therapeutics CAR T-Cell Therapy Agents Introduction
11.5.4 JW Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.5.5 JW Therapeutics Recent Developments
11.6 FOSUNKite
11.6.1 FOSUNKite Company Details
11.6.2 FOSUNKite Business Overview
11.6.3 FOSUNKite CAR T-Cell Therapy Agents Introduction
11.6.4 FOSUNKite Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.6.5 FOSUNKite Recent Developments
11.7 CARsgen Therapeutics (Pipeline)
11.7.1 CARsgen Therapeutics (Pipeline) Company Details
11.7.2 CARsgen Therapeutics (Pipeline) Business Overview
11.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Introduction
11.7.4 CARsgen Therapeutics (Pipeline) Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.7.5 CARsgen Therapeutics (Pipeline) Recent Developments
11.8 CARsgen Therapeutics
11.8.1 CARsgen Therapeutics Company Details
11.8.2 CARsgen Therapeutics Business Overview
11.8.3 CARsgen Therapeutics CAR T-Cell Therapy Agents Introduction
11.8.4 CARsgen Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.8.5 CARsgen Therapeutics Recent Developments
11.9 Autolus Therapeutics
11.9.1 Autolus Therapeutics Company Details
11.9.2 Autolus Therapeutics Business Overview
11.9.3 Autolus Therapeutics CAR T-Cell Therapy Agents Introduction
11.9.4 Autolus Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.9.5 Autolus Therapeutics Recent Developments
11.10 Sorrento Therapeutics
11.10.1 Sorrento Therapeutics Company Details
11.10.2 Sorrento Therapeutics Business Overview
11.10.3 Sorrento Therapeutics CAR T-Cell Therapy Agents Introduction
11.10.4 Sorrento Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.10.5 Sorrento Therapeutics Recent Developments
11.11 Mustang Bio
11.11.1 Mustang Bio Company Details
11.11.2 Mustang Bio Business Overview
11.11.3 Mustang Bio CAR T-Cell Therapy Agents Introduction
11.11.4 Mustang Bio Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.11.5 Mustang Bio Recent Developments
11.12 Bluebird Bio
11.12.1 Bluebird Bio Company Details
11.12.2 Bluebird Bio Business Overview
11.12.3 Bluebird Bio CAR T-Cell Therapy Agents Introduction
11.12.4 Bluebird Bio Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.12.5 Bluebird Bio Recent Developments
11.13 Cellectis
11.13.1 Cellectis Company Details
11.13.2 Cellectis Business Overview
11.13.3 Cellectis CAR T-Cell Therapy Agents Introduction
11.13.4 Cellectis Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.13.5 Cellectis Recent Developments
11.14 Allogene Therapeutics
11.14.1 Allogene Therapeutics Company Details
11.14.2 Allogene Therapeutics Business Overview
11.14.3 Allogene Therapeutics CAR T-Cell Therapy Agents Introduction
11.14.4 Allogene Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.14.5 Allogene Therapeutics Recent Developments
11.15 Celyad
11.15.1 Celyad Company Details
11.15.2 Celyad Business Overview
11.15.3 Celyad CAR T-Cell Therapy Agents Introduction
11.15.4 Celyad Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.15.5 Celyad Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global CAR T-Cell Therapy Agents Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of CD19-targeted
Table 3. Key Players of BCMA-targeted
Table 4. Global CAR T-Cell Therapy Agents Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global CAR T-Cell Therapy Agents Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global CAR T-Cell Therapy Agents Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global CAR T-Cell Therapy Agents Market Share by Region (2018-2024)
Table 8. Global CAR T-Cell Therapy Agents Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global CAR T-Cell Therapy Agents Market Share by Region (2024-2029)
Table 10. CAR T-Cell Therapy Agents Market Trends
Table 11. CAR T-Cell Therapy Agents Market Drivers
Table 12. CAR T-Cell Therapy Agents Market Challenges
Table 13. CAR T-Cell Therapy Agents Market Restraints
Table 14. Global CAR T-Cell Therapy Agents Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global CAR T-Cell Therapy Agents Revenue Share by Players (2018-2024)
Table 16. Global Top CAR T-Cell Therapy Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Therapy Agents as of 2022)
Table 17. Global CAR T-Cell Therapy Agents Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by CAR T-Cell Therapy Agents Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of CAR T-Cell Therapy Agents, Headquarters and Area Served
Table 20. Global Key Players of CAR T-Cell Therapy Agents, Product and Application
Table 21. Global Key Players of CAR T-Cell Therapy Agents, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CAR T-Cell Therapy Agents Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global CAR T-Cell Therapy Agents Revenue Market Share by Type (2018-2024)
Table 25. Global CAR T-Cell Therapy Agents Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global CAR T-Cell Therapy Agents Revenue Market Share by Type (2024-2029)
Table 27. Global CAR T-Cell Therapy Agents Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global CAR T-Cell Therapy Agents Revenue Share by Application (2018-2024)
Table 29. Global CAR T-Cell Therapy Agents Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global CAR T-Cell Therapy Agents Revenue Share by Application (2024-2029)
Table 31. North America CAR T-Cell Therapy Agents Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America CAR T-Cell Therapy Agents Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America CAR T-Cell Therapy Agents Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America CAR T-Cell Therapy Agents Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America CAR T-Cell Therapy Agents Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America CAR T-Cell Therapy Agents Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America CAR T-Cell Therapy Agents Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe CAR T-Cell Therapy Agents Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe CAR T-Cell Therapy Agents Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe CAR T-Cell Therapy Agents Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe CAR T-Cell Therapy Agents Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe CAR T-Cell Therapy Agents Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe CAR T-Cell Therapy Agents Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe CAR T-Cell Therapy Agents Market Size by Country (2024-2029) & (US$ Million)
Table 45. China CAR T-Cell Therapy Agents Market Size by Type (2018-2024) & (US$ Million)
Table 46. China CAR T-Cell Therapy Agents Market Size by Type (2024-2029) & (US$ Million)
Table 47. China CAR T-Cell Therapy Agents Market Size by Application (2018-2024) & (US$ Million)
Table 48. China CAR T-Cell Therapy Agents Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia CAR T-Cell Therapy Agents Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia CAR T-Cell Therapy Agents Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia CAR T-Cell Therapy Agents Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia CAR T-Cell Therapy Agents Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia CAR T-Cell Therapy Agents Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia CAR T-Cell Therapy Agents Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia CAR T-Cell Therapy Agents Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Market Size by Country (2024-2029) & (US$ Million)
Table 63. Novartis Company Details
Table 64. Novartis Business Overview
Table 65. Novartis CAR T-Cell Therapy Agents Product
Table 66. Novartis Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 67. Novartis Recent Developments
Table 68. Gilead Sciences Company Details
Table 69. Gilead Sciences Business Overview
Table 70. Gilead Sciences CAR T-Cell Therapy Agents Product
Table 71. Gilead Sciences Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 72. Gilead Sciences Recent Developments
Table 73. Bristol-Myers Squibb Company Details
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb CAR T-Cell Therapy Agents Product
Table 76. Bristol-Myers Squibb Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 77. Bristol-Myers Squibb Recent Developments
Table 78. J & J Company Details
Table 79. J & J Business Overview
Table 80. J & J CAR T-Cell Therapy Agents Product
Table 81. J & J Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 82. J & J Recent Developments
Table 83. JW Therapeutics Company Details
Table 84. JW Therapeutics Business Overview
Table 85. JW Therapeutics CAR T-Cell Therapy Agents Product
Table 86. JW Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 87. JW Therapeutics Recent Developments
Table 88. FOSUNKite Company Details
Table 89. FOSUNKite Business Overview
Table 90. FOSUNKite CAR T-Cell Therapy Agents Product
Table 91. FOSUNKite Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 92. FOSUNKite Recent Developments
Table 93. CARsgen Therapeutics (Pipeline) Company Details
Table 94. CARsgen Therapeutics (Pipeline) Business Overview
Table 95. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Product
Table 96. CARsgen Therapeutics (Pipeline) Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 97. CARsgen Therapeutics (Pipeline) Recent Developments
Table 98. CARsgen Therapeutics Company Details
Table 99. CARsgen Therapeutics Business Overview
Table 100. CARsgen Therapeutics CAR T-Cell Therapy Agents Product
Table 101. CARsgen Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 102. CARsgen Therapeutics Recent Developments
Table 103. Autolus Therapeutics Company Details
Table 104. Autolus Therapeutics Business Overview
Table 105. Autolus Therapeutics CAR T-Cell Therapy Agents Product
Table 106. Autolus Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 107. Autolus Therapeutics Recent Developments
Table 108. Sorrento Therapeutics Company Details
Table 109. Sorrento Therapeutics Business Overview
Table 110. Sorrento Therapeutics CAR T-Cell Therapy Agents Product
Table 111. Sorrento Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 112. Sorrento Therapeutics Recent Developments
Table 113. Mustang Bio Company Details
Table 114. Mustang Bio Business Overview
Table 115. Mustang Bio CAR T-Cell Therapy Agents Product
Table 116. Mustang Bio Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 117. Mustang Bio Recent Developments
Table 118. Bluebird Bio Company Details
Table 119. Bluebird Bio Business Overview
Table 120. Bluebird Bio CAR T-Cell Therapy Agents Product
Table 121. Bluebird Bio Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 122. Bluebird Bio Recent Developments
Table 123. Cellectis Company Details
Table 124. Cellectis Business Overview
Table 125. Cellectis CAR T-Cell Therapy Agents Product
Table 126. Cellectis Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 127. Cellectis Recent Developments
Table 128. Allogene Therapeutics Company Details
Table 129. Allogene Therapeutics Business Overview
Table 130. Allogene Therapeutics CAR T-Cell Therapy Agents Product
Table 131. Allogene Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 132. Allogene Therapeutics Recent Developments
Table 133. Celyad Company Details
Table 134. Celyad Business Overview
Table 135. Celyad CAR T-Cell Therapy Agents Product
Table 136. Celyad Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 137. Celyad Recent Developments
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CAR T-Cell Therapy Agents Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global CAR T-Cell Therapy Agents Market Share by Type: 2022 VS 2029
Figure 3. CD19-targeted Features
Figure 4. BCMA-targeted Features
Figure 5. Global CAR T-Cell Therapy Agents Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global CAR T-Cell Therapy Agents Market Share by Application: 2022 VS 2029
Figure 7. Lymphoma Case Studies
Figure 8. Multiple Myeloma Case Studies
Figure 9. CAR T-Cell Therapy Agents Report Years Considered
Figure 10. Global CAR T-Cell Therapy Agents Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global CAR T-Cell Therapy Agents Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global CAR T-Cell Therapy Agents Market Share by Region: 2022 VS 2029
Figure 13. Global CAR T-Cell Therapy Agents Market Share by Players in 2022
Figure 14. Global Top CAR T-Cell Therapy Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Therapy Agents as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by CAR T-Cell Therapy Agents Revenue in 2022
Figure 16. North America CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America CAR T-Cell Therapy Agents Market Share by Type (2018-2029)
Figure 18. North America CAR T-Cell Therapy Agents Market Share by Application (2018-2029)
Figure 19. North America CAR T-Cell Therapy Agents Market Share by Country (2018-2029)
Figure 20. United States CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe CAR T-Cell Therapy Agents Market Size YoY (2018-2029) & (US$ Million)
Figure 23. Europe CAR T-Cell Therapy Agents Market Share by Type (2018-2029)
Figure 24. Europe CAR T-Cell Therapy Agents Market Share by Application (2018-2029)
Figure 25. Europe CAR T-Cell Therapy Agents Market Share by Country (2018-2029)
Figure 26. Germany CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. China CAR T-Cell Therapy Agents Market Size YoY (2018-2029) & (US$ Million)
Figure 33. China CAR T-Cell Therapy Agents Market Share by Type (2018-2029)
Figure 34. China CAR T-Cell Therapy Agents Market Share by Application (2018-2029)
Figure 35. Asia CAR T-Cell Therapy Agents Market Size YoY (2018-2029) & (US$ Million)
Figure 36. Asia CAR T-Cell Therapy Agents Market Share by Type (2018-2029)
Figure 37. Asia CAR T-Cell Therapy Agents Market Share by Application (2018-2029)
Figure 38. Asia CAR T-Cell Therapy Agents Market Share by Region (2018-2029)
Figure 39. Japan CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. China Taiwan CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Southeast Asia CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. India CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Australia CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Market Size YoY (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Market Share by Type (2018-2029)
Figure 47. Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Market Share by Application (2018-2029)
Figure 48. Middle East, Africa, and Latin America CAR T-Cell Therapy Agents Market Share by Country (2018-2029)
Figure 49. Brazil CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Mexico CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Turkey CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Israel CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. GCC Countries CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Novartis Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 56. Gilead Sciences Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 58. J & J Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 59. JW Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 60. FOSUNKite Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 61. CARsgen Therapeutics (Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 62. CARsgen Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 63. Autolus Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 64. Sorrento Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 65. Mustang Bio Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 66. Bluebird Bio Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 67. Cellectis Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 68. Allogene Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 69. Celyad Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed